Stronger neominophagen C (SNMC) is a product used in Japan for the treatment of acute and chronic hepatitis. This solution is administered intravenously, 80-200 mg/day, for variable periods of time, and contains 0.2% glycyrrhizin, 0.1% cysteine, and 2% glycine in physiological solution. In the United States, glycyrrhizin is available in a multiplicity of nonstandardized oral formulations found over the country [80, 81] .